DW6013

DRUG2 trials

Sponsors

Dong Wha Pharmaceutical Co. Ltd.

Conditions

Healthy Subjects

Phase 1

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

CompletedNCT05874180

Dong Wha Pharmaceutical Co. Ltd.Healthy Subjects

Start: 2023-01-09End: 2023-02-03Updated: 2023-05-24

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

CompletedNCT05874167

Dong Wha Pharmaceutical Co. Ltd.Healthy Subjects

Start: 2022-08-08End: 2022-10-11Updated: 2023-05-24